Trial
NCT06521762
Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Yale University
Collaborators
Pfizer
Condition
Immune Checkpoint Inhibitor-Related Diarrhea and Colitis
Intervention
Etrasimod
Why stopped
The study was terminated early as no patients were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-14